Sun Pharma News: Read Latest News & Live Updates on Sun Pharma, Photos, Videos at CNBCTV18.com

homeSun Pharma News

Sun Pharma NEWS

All

market | Apr 12, 2024 1:53 PM IST
Pharma Q4FY24 earnings preview | Robust US performance expected to drive revenue growth
market | Mar 19, 2024 8:59 AM IST
Sun Pharma gets Australian regulator's nod for acne drug Winlevi
market | Mar 10, 2024 11:17 AM IST
Sun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violation
market | Feb 1, 2024 4:27 PM IST
Sun Pharma growth prospects intact; share gets 'Buy' call as positive earnings surprise continue
earnings | Jan 31, 2024 2:31 PM IST
Sun Pharma Q3 Results: US formulation sales up 13%, margin beats estimates
market | Jan 29, 2024 11:49 AM IST
Sun Pharma shares rise 4% after strong set of earnings from Taro
healthcare | Jan 25, 2024 9:00 AM IST
India may consider restricting fluoroquinolone antibiotics just like the UK did
market | Jan 18, 2024 5:00 AM IST
Sun Pharma to acquire remaining outstanding shares of Taro for ₹2,891 crore
market | Jan 17, 2024 2:02 PM IST
Sun Pharma gets non-exclusive rights to sell Kidney disease treatment drug in India
healthcare | Jan 15, 2024 10:38 PM IST
Pharma Q3FY24 outlook: What the Street anticipates
market | Dec 18, 2023 2:41 PM IST
Sun Pharma among 20 most valued Indian companies after market cap crosses ₹3 lakh crore
market | Dec 12, 2023 5:10 AM IST
Sun Pharma increases offer price to acquire remaining outstanding shares of Taro
market | Dec 6, 2023 5:02 AM IST
Sun Pharma subsidiary signs licensing agreement with biopharma company Aclaris Therapeutics
business | Nov 2, 2023 7:14 PM IST
Speciality sales factored into FY24 revenue guidance of high single-digit growth: Sun Pharma CFO
market | Nov 2, 2023 10:19 AM IST
Improving speciality biz outlook, margin gains keep Street positive on Sun Pharma stock

Sun Pharma NEWS

Pharma Q4FY24 earnings preview | Robust US performance expected to drive revenue growth

Sun Pharma gets Australian regulator's nod for acne drug Winlevi

Sun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violation

Sun Pharma growth prospects intact; share gets 'Buy' call as positive earnings surprise continue

Sun Pharma Q3 Results: US formulation sales up 13%, margin beats estimates

Sun Pharma shares rise 4% after strong set of earnings from Taro

India may consider restricting fluoroquinolone antibiotics just like the UK did

Sun Pharma to acquire remaining outstanding shares of Taro for ₹2,891 crore

Sun Pharma gets non-exclusive rights to sell Kidney disease treatment drug in India

Pharma Q3FY24 outlook: What the Street anticipates

Sun Pharma among 20 most valued Indian companies after market cap crosses ₹3 lakh crore

Sun Pharma increases offer price to acquire remaining outstanding shares of Taro

Sun Pharma subsidiary signs licensing agreement with biopharma company Aclaris Therapeutics

Speciality sales factored into FY24 revenue guidance of high single-digit growth: Sun Pharma CFO

Improving speciality biz outlook, margin gains keep Street positive on Sun Pharma stock